TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ASND

Ascendis Pharma AS

Healthcare · Biotechnology

228.00$ +0.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Ascendis Pharma AS (ASND) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,285 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ASND
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
87 190 173 142 222 211 365 369 335 319 762 767 735 677 677 561 1,046 980 965 852 1,205 1,085 1,377 1,327 1,273 1,090 966 824 873 826 803 758 1,094 1,179 1,061 1,088 1,155 1,302 2,005 2,285
81 184 166 136 216 205 358 362 327 293 716 703 670 611 611 492 954 740 687 584 957 806 1,121 1,112 1,080 923 810 678 733 703 664 627 974 1,061 921 953 1,018 1,109 1,124 1,390
75 180 158 127 206 195 348 353 310 278 697 690 659 598 598 241 763 585 495 385 693 446 756 672 608 445 501 394 441 392 320 259 626 560 518 494 539 616 573 812
75 180 158 127 206 195 348 353 310 278 697 690 659 598 598 472 930 719 665 551 858 682 979 955 920 735 586 431 455 399 320 259 626 560 518 494 539 616 573 812
0.4 0.3 0.4 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.0 2.6 3.1 0.8 5.4 7.0 2.7 0.4 0.1 0.4 0.5 2.2 5.8 4.4 6.7 12 16 20 27 36 41 49 33 166 67 110 147 158 197 224
0.0 – – 0.0 0.0 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – 0.0 0.0 0.0 55 75 92 101 104 131 151 168 189 209 233 251 265 296 293 303 302 301 315 310
2.7 2.5 2.7 3.0 3.0 3.1 3.0 3.0 4.7 6.5 24 43 43 45 50 50 47 108 114 124 126 126 128 133 139 129 – 125 126 – – – – – – – – – – –
3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.5 3.8 4.7 3.5 0.0 – – 3.5 – 5.0 4.9 3.5 – – – 3.5 – – – 3.5 – – – 3.5 3.7 –
3.5 3.7 3.7 3.5 3.5 3.5 23 167,436 1,004,825,454 4.0 4.4 12 116,980 4.4 – – – 2.2 5.6 5.5 5.4 1.8 5.2 0.0 0.0 1.3 4.7 4.6 4.5 0.9 4.3 4.2 4.1 0.5 3.9 3.8 3.7 0.2 – 3.7
12 13 18 16 20 24 17 37 31 39 45 92 74 80 80 83 95 141 162 164 212 201 704 719 822 826 799 759 947 971 1,041 1,079 1,191 1,285 1,251 1,275 1,329 1,465 1,517 849
12 13 18 16 20 24 17 37 31 39 32 61 43 48 48 54 64 53 73 70 116 100 95 115 143 171 198 192 213 737 799 848 838 908 886 935 986 1,069 1,128 465
– – – – – – 0.0 0.0 0.0 0.0 4.3 4.8 5.4 5.9 5.9 6.4 6.3 6.9 6.9 7.0 6.7 14 8.9 14 20 25 25 27 26 435 439 454 450 492 490 462 482 486 511 65
11 13 17 16 20 17 17 37 31 20 19 21 24 28 28 32 38 22 54 44 76 59 71 75 86 101 131 122 122 95 95 100 75 96 84 94 79 91 79 104
– – – – – – 0.0 0.0 0.0 0.0 207,095,419,143 0.0 0.0 0.0 – – – – – – – – – 498 533 483 480 479 549 534 230 219 339 365 357 330 331 385 386 385
74 177 155 126 202 187 347 332 304 280 717 675 661 597 597 477 952 839 803 687 994 884 673 608 452 263 167 65 -73 -146 -238 -321 -97 -106 -190 -188 -174 -163 488 1,436
60 -139 135 104 177 -263 -305 -327 -361 -393 -447 -506 -531 -611 -611 -770 -891 -1,030 -1,093 -1,227 -1,308 -1,236 -1,539 -1,621 -1,790 -1,860 -1,958 -2,059 -2,204 -2,277 -2,391 -2,474 -2,547 -2,560 -2,658 -2,666 -2,705 -2,699 -2,086 -1,878
25 32 32 33 33 39 39 42 42 43 43 47 48 48 48 48 53 54 54 54 55 54 57 56 56 56 56 56 56 57 57 57 59 60 60 64 61 61 65 68

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?